/Companies

CytoImmune Therapeutics

Monrovia, US · Founded 2020 · Delaware corporation

Find your way into CytoImmune Therapeutics

Sign up to see every warm intro you have to CytoImmune Therapeutics

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the CytoImmune Therapeutics team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Founders & leadership

WR
Will RoselliniNamed on SEC filing
RT
Richard T SantulliNamed on SEC filing
DW
Douglas WilliamsNamed on SEC filing
KH
Kinam HongNamed on SEC filing
AKAleksey Krylov
Aleksey KrylovChief Financial Officer2020–2023Angel investor

Reported raises · per SEC filings

Form D private placements

$36.5M disclosed across 1 round · 2021

▶$36.5MraisedAug 2021 · 4 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Will RoselliniExecutive Officer
  • Richard T SantulliExecutive Officer
  • Douglas WilliamsDirector
  • Kinam HongDirector
  • Aleksey KrylovExecutive Officer
Offering amount
$100.3M
Amount sold
$36.5M
Sales commissions
$880K
Placement agents
Lifesci Capital
First sale
Jul 2021
Incorporated
Corporation, Delaware, 2020
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

How much funding has CytoImmune Therapeutics raised?
CytoImmune Therapeutics has disclosed $36.5M raised across 1 round.
Where is CytoImmune Therapeutics headquartered?
CytoImmune Therapeutics is headquartered in Monrovia, US.